STING1 and triple-negative breast carcinoma: Although the hNVs alone showed mild antitumor effect in a poorly immunogenic triple negative breast carcinoma model, STING agonist, cGAMP-loaded hNVs significantly inhibited the post-surgical recurrence and metastasis by reprogramming ‘cold’ tumors towards immunogenic states.